New Key Statistics Module, Z-Score and F-Score
NAS:ARWR Key Ratios
| Market Cap $ M | 2,709.63 |
| Enterprise Value $ M | 2,783.86 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 14.68 |
| Price/Sales | 12.92 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 181.00 |
| EPS (TTM) $ | -2.77 |
| Beneish M-Score | -4.9 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -9.85 |
| EV-to-EBITDA | -10.37 |
| PEG | -- |
| Shares Outstanding M | 123.90 |
| Net Margin (%) | -163.32 |
| Operating Margin % | -164.75 |
| Pre-tax Margin (%) | -166.93 |
| Quick Ratio | 3.73 |
| Current Ratio | 3.73 |
| ROA % (ttm) | -37.38 |
| ROE % (ttm) | -91.59 |
| ROIC % (ttm) | -81.36 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.37 |
ARWR Number of Guru Trades
ARWR Volume of Guru Trades
Gurus Latest Trades with NAS:ARWR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARWR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arrowhead Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ARWR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers